glp 1 agonist statpearls Beyond glycemia: Comparing tirzepatide to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders Glucagon-like peptide-1 receptor agonists: a

In the SURMOUNT-5 head-to-head against semaglutide, tirzepatide produced 47% greater relative weight loss

That cross-substance signal points to a shared biology underlying addiction, and it opens the door to a fundamentally different approach: not treating one addiction at a time, but targeting that common biologic signal, that common craving across addictions

Journal of Nutritional Science and Vitaminology

L.YangZ.et al (2022)

As other members of this medication class, they were originally developed as glucose-lowering agents for type 2 diabetes

However, most studies of pancreatic mass or exocrine cellular proliferation have reported no change with exenatide, liraglutide, or dulaglutide (86, 108, 109, 119, 121)